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To study the effect on plasma 25-hydroxycholecalciferol (25(OH)D), 1,25-dihydroxycholecalciferol 
(1,25(OH),D) and parathyroid hormone (PTH) we supplemented premenopausal (aged 30 (SD 7) years) 
and postmenopausal (aged 61 (SD 2) years) white women living in The Netherlands in late winterlearly 
spring, and elderly black and white women (aged 75 (SD 6) years) living in Curacao (Dutch Antilles) with 
either 10 or 20pg cholecalciferol/d for 4, 5 and 9 weeks respectively. Baseline plasma 25(OH)D 
concentration of Dutch women was lower than that of Curacao women. Postmenopausal Dutch women 
had a higher PTH concentration in plasma than premenopausal Dutch and postmenopausal Curacao 
women. There were no differences in plasma 1,25(OH),D. Cholecalciferol administration increased 
25(OH)D in all groups, 1,25(OH),D in postmenopausal Curacao women and PTH in postmenopausal 
Curacao women and premenopausal Dutch women. Serum and urinary Ca and phosphate concentrations 
did not change. There were no response differences between 10 and 20 pg doses. Oral cholecalciferol 
administration (either 10 or 20 pg/d) to women living at northern latitudes in late winterlearly spring 
increased 25(OH)D levels to the baseline levels of elderly people living in the tropics. 
Cholecalciferol : Parathyroid hormone : Osteoporosis 
Vitamin-D deficiency is rare among people living in tropical climates as long as they 
regularly expose themselves to sunlight. We recently reported (Dubbelman et al. 1993; 
Jonxis et  al. 1993) higher 25-hydroxycholecalciferol(25(OH)D) and somewhat higher 1,25- 
dihydroxycholecalciferol (1,25(OH),D) plasma levels in postmenopausal white women 
living in the tropics (Curaqao, The Netherlands Antilles; 12.1 5" north latitude), compared 
with counterparts living at more northerly latitudes (The Netherlands; 52" north). (In the 
present paper, for the sake of simplicity, women living in The Netherlands and Curaqao are 
* Professor Jonxis died on 26 July 1995. 
t For reprints. 
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described as ‘Dutch’ and ‘Curaqao’ women respectively, although all of them have Dutch 
nationality.) Vertebral compression fractures commonly encountered in postmenopausal 
white women living at higher latitudes were absent in Curaqao counterparts. These 
differences may be explained by the abundant sunlight in the tropics all the year round, 
which, in contrast to higher latitudes, favours year-long vitamin-D synthesis. We suggested 
that cholecalciferol administration to women from the menopause onwards and possibly 
also to elderly men, in an amount that raises plasma 25(OH)D levels to those of CuraGao 
women, may delay the occurrence of osteoporotic lesions. In the present study we 
investigated whether cholecalciferol administration to premenopausal and postmenopausal 
Dutch women would raise late winter/early spring plasma 25(OH)D levels to baseline 
25(OH)D levels seen in Curaqao. 
SUBJECTS A N D  METHODS 
Subjects 
A total of 105 women were enrolled in the study. They were ambulatory and had no major 
ailments. They comprised : (1) forty-one (twenty black, twenty-one white) postmenopausal 
CuraGao women, aged 64-89 years, mean 75.3 (SD 5.8) years; (2) fifty-eight postmenopausal 
white Dutch women, aged 5465  years, mean 61.2 (SD 2.4) years, and (3) six apparently 
healthy premenopausal white Dutch women, aged 23-40 years, mean 301 (SD 6.9) years. 
Five of the premenopausal women took oral contraceptives. 
None of the women used drugs known to alter vitamin-D or bone metabolism (e.g. 
anticonvulsants, corticosteroids and postmenopausal oestrogens). Informed consent was 
obtained from all subjects. The study was in agreement with local ethical standards and the 
Helsinki declaration of 1975, as revised in 1989. 
Study design 
The women having supplementary cholecalciferol received 10 or 20 pg oral cholecalciferol 
(Duphar bv, The Netherlands)/d. Twenty postmenopausal Dutch women were given a 
placebo. The women were randomly assigned to receive placebo, 10 or 2Opg 
cholecalciferol /d. 
Postmenopausal black (n 20) and white (n 21) Curacao women. Supplementary cholecal- 
ciferol was given for 9 weeks (from October to December 1992). Ten black and ten white 
women received 20 pg/d as a single dose. Ten black and eleven white women received an 
equal daily amount, administered as two doses of 10 pg during the day. Plasma 25(OH)D, 
1,25(OH),D and parathyroid hormone (PTH), serum Ca and phosphate, and urinary Ca, 
phosphate and creatinine concentrations were determined before and after 1, 5 and 9 weeks 
supplementation. 
Postmenopausal white Dutch women (n 58). Cholecalciferol was administered for 5 weeks 
in late winter/early spring (from 6 April to 13 May 1993). The women received daily doses 
of 20 pg cholecalciferol (n 19), 10 pg cholecalciferol (n 19), or 135 mg cellulose (placebo; 
n 20). To avoid detection of dissimilarity between supplements, cholecalciferol was 
administered in cellulose-filled capsules that resembled the placebo. Plasma 25(OH)D, 
1,25(OH),D and PTH, and serum Ca and phosphate concentrations of all women were 
determined before and after 5 weeks supplementation. 
Premenopausal white Dutch women (n 6). Cholecalciferol was administered for 4 weeks 
in late winter (from 4 March to 1 April 1992). The women received 20 pg cholecalciferol 
daily. Plasma 25(OH)D, 1,25(OH),D and PTH were determined before and after 4 weeks. 
Serum Ca and phosphate were measured weekly. 
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Sampling, sample processing and analytical methods 
Blood and EDTA-anticoagulated blood were collected by venepuncture for the preparation 
of serum and plasma respectively. Samples of urine were collected after morning voidance 
and after a subsequent 2 h fast. These were either analysed immediately or stored at -20" 
until analysed. Serum and urinary Ca and phosphate concentrations of the Curaqao women 
were determined in the local Public Health Laboratory. Plasma, serum and urine 
remainders were transported to The Netherlands in solid CO, for further analysis in the 
University Hospital Groningen. 
Serum and urinary Ca (ortho cresolphthalein complexone method) and phosphate 
(molybdate method), and urinary creatinine (picric acid method) were measured with a 
Kodak Ektachem 500 (Eastman Kodak Company, Rochester, NY, USA) in The 
Netherlands and a Beckman Astra-8 autoanalyser (Beckman, Fullerton, CA, USA) in 
Curaqao. Reference ranges for serum Ca and phosphate were: 2.25-2.75 and 
0.74-1.52 mmol/l (The Netherlands), and 2.20-2.60 and 0.70-1.60 mmol/l (Curaqao) 
respectively. Between-series coefficients of variation (CV) for serum Ca and phosphate 
concentrations in the reference ranges amounted to: 1.2 and 1.5 % (The Netherlands) and 
1.5 and 2.0% (CuraCao) respectively. Intact PTH (PTH amino acids 1-84) was measured 
with a two-site immunoradiometric assay (IRMA) by using the commercial kit of the Incstar 
Corporation (Stillwater, MN, USA). The between-series CV for quality-control samples at 
3.4, 20.0 and 32.5 pmol/l were 9-2, 9.2 and 9.6% respectively. 25(OH)D, and 25(OH)D, 
were measured as 25(OH)D, by using solid-phase prepurification followed by a competitive 
radio-binding assay with tritium-labelled 25(OH)D, and vitamin D-binding protein from 
human serum. Between-series CV at 16, 62 and 101 nmol/l were 13, 12 and 13 YO 
respectively. 1,25(OH),D, and 1,25(OH),D, were determined as 1,25(OH),D with the kit 
of the Incstar Corporation, based on solid-phase prepurification followed by a competitive 
radioreceptor assay with tritium-labelled 1,25(OH),D, and a thymus receptor. The 
between-series CV at 25, 93, and 138 pmol/l were 21, 16, and 14% respectively. 
Statistical analyses 
Independent t tests were used for establishing between-group differences before sup- 
plementation (Table 1). Values of P < 0.05 were considered significant. Longitudinal 
results from the Curaqao study were analysed by repeated measurement (ANOVA ; 
Stevens, 1986). Values that showed supplementation effects were subsequently investigated 
by the modified Tukey post-hoc procedure for one-sample repeated measurements at P < 
0.05. After verification of parallel line assumption, coincidences of analyte courses of 
different Curaqao groups (black v. white; 2 x 10 v. 20 pg) were tested with repeated 
measurement analysis. Dependent t tests were used for longitudinal data from the two 
Dutch studies. Values of P < 0.05 were considered significant. For between-group 
comparison of data obtained from two sampling points during the study, analyses of 
covariance (ANCOVA) were used, with time as covariate. An example is the analysis of 
differences in 25(OH)D courses of postmenopausal Curaqao and Dutch women from 
baseline to 4-5 weeks supplementation. 
RESULTS 
Baseline values 
Baseline values for plasma 25(OH)D, 1,25(OH),D and PTH of women in all groups are 
given in Table 1. The black and white postmenopausal Curaqao women taking part in the 
study did not differ in age, or in plasma 25(OH)D, 1,25(OH),D and PTH concentrations. 
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Table 1. Plasma 25-hydroxycholecalciferol (25(0H)D), I ,  25-dihydroxycholecalciferol 
( I ,  25(0H),D) and parathyroid hormone (PTH) concentrations in postmenopausal black 
and white Curagao women, and postmenopausal and premenopausal white Dutch women in 
late winter 
(Mean values and standard deviations) 
Age 25(OH)D 1,25(OH),D PTH 
(years) (nmol/l) (pmol/l) (pmol/l) 
n Mean SD Mean SD Mean SD Mean SD 
Post Cur, black 20 73.8 4.0 88.3 28.2 98.0 53.5 2.3 1.3 
Post Cur, white 21 75.4 7.1 82.0 25.8 78.6 46.3 1.9 1.1  
Post Cur, all 41 75.3 5.8 85.1 26.9 88.3 504 2.1 1.2 
Post Neth 58 61.2***? 2 4  585***t  234 91.7 32.1 3-9***? 1.3 
R e  Neth 6 301*** 6.9 46.2*** 13.3 81.9 29.6 1.9 1.4 
Post, postmenopausal; Pre, premenopausal; Cur, Curacao; Neth, The Netherlands; Post Cur all, pooled data 
*** Mean values were significantly different from pooled value for black and white postmenopausal women in 
t Mean values were significantly different from those for premenopausal women in The Netherlands 
from black and white postmenopausal women in Curacao. 
Curacao (P c 0.001). 
(P < 0.02). 
For comparison with values for premenopausal and postmenopausal Dutch women the 
CuraCao women were, therefore, considered as a single group. 
Plasma 25(OH)D concentration of the elderly CuraGao women was higher than that of 
the young and elderly Dutch women and plasma 25(OH)D concentration of the elderly 
Dutch women was higher than that of the young Dutch women. 
There were no differences in plasma 1,25(OH),D between the groups. Plasma PTH of the 
elderly Dutch women was higher than that of the young Dutch women and of the elderly 
Curacao women. Premenopausal Dutch women and the elderly CuraGao women did not 
differ in plasma PTH. Baseline serum Ca and phosphate of all women, and urinary 
Ca : creatinine, phosphate : creatinine and Ca: phosphate ratios of postmenopausal Curacao 
women were within the reference ranges of our laboratory. 
Effects of cholecalciferol and placebo 
Fig. 1 shows the changes in plasma 25(OH)D, 1,25(OH),D and PTH following 
cholecalciferol supplementation of postmenopausal black and white CuraGao women (a), 
postmenopausal Dutch women (b) and premenopausal Dutch women (c). The changes in 
plasma 25(OH)D, 1,25(OH),D and PTH following placebo administration to post- 
menopausal Dutch women are given in Fig. 2. 
Postmenopausal CuraGao women. There were no significant differences in baseline plasma 
25(OH)D, 1,25(OH),D or PTH concentrations between black (n 20) and white (n 21) 
postmenopausal Curacao women. Changes following cholecalciferol administration were 
also similar in the two groups, and similar also whether the vitamin was taken as 20 pg once 
daily or in two doses of 1Opg (results not shown). Black and white postmenopausal 
Curacao women were therefore considered as a single group (Fig. 1 (a)). The pooled data 
showed that supplementation caused statistically significant increases of 25(OH)D, 
1,25(OH),D and PTH. Stable levels were reached within 1 week. Serum Ca and phos- 
phate, and urinary Ca : creatinine, phosphate : creatinine and Ca: phosphate ratios did not 
change. Mean serum concentrations at baseline and after 9 weeks supplementation were: Ca 
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Fig. 1. Courses of plasma 25-hydroxycholecalciferol(25(OH)D; .), I ,  25-dihydroxycholecalciferol(1,25(OH),D ; 
W) and parathyroid hormone (PTH; +) concentration in (a) postmenopausal black (n 20) and white (n 21) 
Curacao women, (b) postmenopausal white Dutch women (n 38) and (c) premenopausal white Dutch women (n 6) 
following cholecalciferol supplementation (10 or 20 ,ug/d). Values for 25(OH)D are nmol/l; those for 1,25(OH),D 
and PTH are pmol/l. For details of subjects and procedures see pp. 638-639. Values are means with their standard 
errors represented by vertical bars. Repeated measurements statistics and dependent t tests revealed time- 
dependent increases of 25(OH)D levels in all groups, of 1,25(OH),D in postmenopausal Curapao women, and of 
PTH levels in postmenopausal Curapao women and premenopausal Dutch women (uninterrupted lines). 
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Fig. 2. Courses of plasma 25-hydroxycholecalciferol(25(OH)D; .), 1,25-dihydroxycholecalciferol(1,25(OH),D; 
m) and parathyroid hormone (PTH; +) concentration following administration of cellulose (placebo) to 
postmenopausal white Dutch women (n 20). For details of subjects and procedures see pp. 638-639. Values for 
25(OH)D are nmol/l; those for 1,25(OH),D and PTH are pmol/l. Values are means with their standard errors 
represented by vertical bars. Repeated measurements statistics and dependent t tests revealed no changes. 
2.30 (SD 0.20) and 2.47 (SD 0.1 1) mmol/l and phosphate 1.16 (SD 0.15) and 
1.13 (SD 0.15) mmol/l respectively. 
Postmenopausal Dutch women. Baseline values of 25(OH)D, 1,25(OH),D and PTH, and 
their changes during cholecalciferol supplementation were not different for postmenopausal 
Dutch women who received 10 (n  19) or 20 (n 19) pg/d (results not shown). The pooled 
data showed that 25(OH)D, but not 1,25(OH),D and PTH, increased (Fig. 1 (b)). There 
were no significant changes in the twenty postmenopausal Dutch women receiving placebo 
(Fig. 2). Administration of cholecalciferol or placebo did not affect serum Ca and 
phosphate. Mean serum concentrations for vitamin-D-supplemented women at baseline 
and after 5 weeks were: Ca 2.47 (SD 0.20) and 2.44 (SD 0.15) mmol/l and phosphate 
1.23 (SD 0.19) and 1.26 (SD 0.12) mmol/l respectively. 
Premenopausal Dutch women. In premenopausal women receiving cholecalciferol the 
25(OH)D and PTH levels rose markedly, whereas 1,25(OH),D levels did not change (Fig. 
l(c)). Their serum Ca and phosphate concentrations did not change. Mean serum 
concentrations at baseline and after 4 weeks were: Ca 2.41 (SD 0.13) and 
2.50 (SD 0.08) mmol/l and phosphate 1.07 (SD 0.07) and 1.13 (SD 0.12) mmol/l respectively. 
Changes and endpoints in plasma 25(0H)D following cholecalciferol supplementation. 
Following 5 weeks supplementation with 10 or 20 pg cholecalciferol/d, postmenopausal 
Dutch women reached mean plasma 25(OH)D levels of 87.9 (SD 28.1) nmol/l (n 38). These 
levels were not significantly different from baseline levels of postmenopausal Curagao 
women (mean 85.1 (SD 269) nmol/l; n 41 ; Table 1). They were, however, lower than 
25(OH)D levels of postmenopausal Curaqao women after 5 weeks supplementation with 20 
or 2 x 10 pg/d (mean 102.6 (SD 28.8) nmol/l; n 41). The changes in plasma 25(OH)D of 
postmenopausal and premenopausal Dutch women were similar (parallel, coincident), but 
both significantly different from those of postmenopausal Curaqao women (parallel, but 
not coincident). 
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DISCUSSION 
Plasma 25(OH)D concentration usually decreases with advancing age, a condition 
associated with development of secondary hyperparathyroidism and increasing osteo- 
porosis risk (Khaw et al. 1992). Nevertheless, compared with their significantly younger 
Dutch counterparts the postmenopausal women in Curacao had higher plasma 25(OH)D, 
lower PTH and similar 1,25(OH),D concentrations (Table 1). These findings are at 
variance with those of our previous study (Dubbelman et al. 1993) in which postmenopausal 
women in Curaqao had higher 25(OH)D, similar PTH and higher 1,25(OH),D 
concentrations. A possible explanation is that the present postmenopausal Dutch women 
(61.2 (SD 2.4) years) were considerably younger than their previously studied institution- 
alized Dutch counterparts (63-83 years). Compared with our previous findings from 
premenopausal Dutch women the present group of premenopausal Dutch women showed 
similar plasma 25(OH)D, 1,25(OH),D, and PTH concentrations. Those of 25(OH)D and 
1,25(OH),D were found to be lower, compared with Curaqao counterparts (Dubbelman et 
al. 1993). Following 4 weeks vitamin-D supplementation, premenopausal Dutch women 
exhibited still lower 25(OH)D, but somewhat higher 1,25(OH),D and FTH concentrations, 
compared with baseline values of premenopausal Curacao women (Dubbelman et al. 1993). 
Higher plasma 25(OH)D concentrations in Curaqao are caused by year-long, season- 
independent, abundant sunlight, which favours vitamin-D synthesis in skin. Curaqao is a 
tropical island located in the Caribbean sea at 12" north latitude. The island is 
predominantly inhabited by subjects of West-African origin. Most white women are of 
Dutch descent. Dietary habits are essentially Western, with a generally low intake of Ca 
because of low milk consumption. 
We did not observe differences in baseline plasma 25(QH)D concentrations of black and 
white postmenopausal CuraCao women. This finding is in agreement with a study of Meier 
et al. (1991), who found similar 25(OH)D concentrations in premenopausal black and 
white women living in the New York City area. However, Bell et al. (1985) found lower 
25(OH)D concentrations in young blacks living in South Carolina. In contrast to white 
subjects, black subjects did not show a rise in serum vitamin D and 25(OH)D, following 
a single exposure to a relatively small ultraviolet radiation dose (Clemens et al. 1982). The 
observation is explained by lower previtamin D, synthesis rate in pigmented skin (Holick 
et al. 1981). 
The present study shows that placebo-controlled (postmenopausal Dutch women) and 
placebo-uncontrolled (postmenopausal CuraCao women and premenopausal Dutch 
women) administration of 10 or 20pg cholecalciferol/d for 4-5 weeks during late 
winter/early spring raised the concentration of 25(OH)D in the plasma of premenopausal 
and postmenopausal women living in a northern latitude (The Netherlands) to those of 
postmenopausal women living in the tropics (Curaqao). The similarity in response to 
supplementation with 10 ,ug/d and 20 pg/d suggests that the lower dose is adequate. It is 
conceivable that a smaller dose might have the same effect. The treatment had no effect on 
serum Ca and phosphate concentrations (all women), or on urinary Ca and phosphate 
excretion (Curaqao), which implies that no short-term toxic effects are likely to occur. 
Vitamin-D toxicity has been reported when young children were given 45 pg or more 
daily, but young children are especially sensitive to vitamin-D toxicity (National Research 
Council, 1989). A high concentration of 25(OH)D in plasma may play a role in this. The 
highest 25(OH)D level in the present study was 188 nmol/l. Hypercalcaemia and 
hyperphosphataemia due to vitamin-D intoxication are usually accompanied by plasma 
25(OH)D levels above 375 nmol/l (Holick, 1994). 
Absolute increases of plasma 25(OH)D following 4-5 weeks cholecalciferol sup- 
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plementation were similar in premenopausal and postmenopausal Dutch and post- 
menopausal Curaqao women. Taking all data together, the median 25(OH)D increase 
amounted to 24 nmol/l. Our results indicate that in the 10,20 and 2 x 20 pg dose range the 
absolute 25(OH)D increase tended to some degree to be independent of baseline plasma 
25(OH)D, daily dose or frequency of administration of a given dose. 
Similar effects of 10 and 20 ,ug have been reported previously (Lips et al. 1988), and seem 
to argue against the notion that conversion of cholecalciferol to 25(OH)D is loosely 
regulated (Norman, 1990; Holick, 1994). Considering the similarity in 25(OH)D responses 
following a single 20 or a 2 x 10 pg daily dose, it is hardly conceivable that in this dose range 
gastrointestinal fractional cholecalciferol absorption decreases with increasing cholecal- 
ciferol dose. 
A possible explanation for the similarity in plasma 25(OH)D responses following 10 and 
20 pg cholecalciferol/d is that, like vitamin E and carotenoids (Traber & Kayden, 1987; 
Kaplan et al. 1990), adipose tissue and other organs function as vitamin-D-buffering 
systems. Humans have the capacity to store circulating cholecalciferol, notably in adipose 
tissue and muscle (Mawer et al. 1972). Cholecalciferol taken orally probably leads to a 
different body distribution from that resulting from synthesis in skin. Cholecalciferol is 
believed to be removed from skin by binding to the vitamin-D-binding protein (Holick et 
al. 198 l), whereas orally administered cholecalciferol enters the body via chylomicrons 
(Holick, 1994). 
At present the effects of cholecalciferol are best described as maintenance of extracellular 
Ca and phosphate in a supersaturated state which results in bone mineralization (Holick, 
1994). This thesis is supported by studies that showed beneficial effects of cholecalciferol 
supplementation in prevention or postponement of postmenopausal osteoporosis (Dawson- 
Hughes et al. 1991; Chapuy et al. 1992) and our observation that, in contrast to white 
women living in northern latitudes, postmenopausal white CuraCao women do not show 
signs of compression fractures of their lumbar vertebrae (Dubbelman et al. 1993). The 
young Dutch women had baseline PTH levels similar to those of the elderly Curaqao 
women, whereas those of the elderly Dutch women were higher (Table 1). Since high PTH 
levels are usually associated with bone Ca resorption, it is likely that premenopausal Dutch 
women (because of the protective influence of oestrogens on bone resorption) and 
postmenopausal Curaqao women (because of their better vitamin-D status) were in, or 
close to, bone Ca balance, whereas postmenopausal Dutch women (because of their lower 
vitamin-D status and lack of oestrogen protection) were in negative bone Ca balance. 
Lips et al. (1988) reported 15 % decreases of plasma PTH after 3 months cholecalciferol 
supplementation of two groups of elderly Dutch women (81 (SD 9) and 84 (SD 6) years) with 
very low baseline 25(OH)D levels (23.6 (SD 8.9) and 23.8 (SD 13.3) nmol/l respectively). 
Their results and those of others (Dawson-Hughes et al. 1991; Chapuy et al. 1992) 
suggested that secondary hyperparathyroidism-induced bone Ca resorption diminished. 
We did not observe plasma FTH changes in postmenopausal Dutch women (mean 61 (SD 2) 
years) after 5 weeks cholecalciferol supplementation (Fig. 1 (b)). Decrease of PTH may take 
longer than 5 weeks. Quite unexpectedly, cholecalciferol supplementation caused PTH to 
increase in premenopausal Dutch women (mean 30 (SD 7) years; Fig. 1 (c)), and both PTH 
and 1,25(OH),D to increase in postmenopausal CuraGao women (mean 75 (SD 6) years; 
Fig. 1 (a)). The increase in plasma 1,25(OH),D of premenopausal Dutch women did not 
reach statistical significance, probably because of the small number of subjects investigated. 
Because of oestrogen protection (premenopausal Dutch women) and high baseline vitamin 
D status (postmenopausal Curaqao women), we speculate that we are dealing with a 
natural reaction in women who are probably in bone Ca balance. Similar responses of PTH 
and 1,25(OH),D were observed following administration of oestrogens to postmenopausal 
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women. Stock et al. (1985) found that PTH (amino acids 44-68) concentration decreased 
after 2 weeks and subsequently increased after 8 weeks, whereas 1,25(OH),D concentration 
was higher from 2 weeks. 
In conclusion, this study shows that 4-5 weeks oral administration of 10 and 20pg 
cholecalciferol/d to premenopausal and postmenopausal white women in late winter/early 
spring causes plasma 25(OH)D to reach baseline levels characteristic of postmenopausal 
women living in the tropics. A daily dose of 10pg appears to be sufficient. The good 
condition of the lumbar vertebrae of postmenopausal white CuraGao women suggests that 
prevention of the decline in the plasma 25(OH)D in winter reduces bone demineralization 
of postmenopausal women living in northern latitudes (Jonxis, 1994). 
Note by Professor J.  H .  P.  Jonxis added during editing 
The Committee on Nutrition of the Elderly of The Food and Nutrition Council of the 
Netherlands has recommended that men and women aged 65-75 years who are exposed to 
sunlight during the summer months should take a supplement of 2.5 pg vitamin D/d. Those 
aged 65-75 years who are rarely exposed to sunlight, and all men and women aged over 75 
years, should take a daily supplement of 7.5-10 pg. 
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